JPS6450824A - Improved immunity for mammals - Google Patents

Improved immunity for mammals

Info

Publication number
JPS6450824A
JPS6450824A JP20104787A JP20104787A JPS6450824A JP S6450824 A JPS6450824 A JP S6450824A JP 20104787 A JP20104787 A JP 20104787A JP 20104787 A JP20104787 A JP 20104787A JP S6450824 A JPS6450824 A JP S6450824A
Authority
JP
Japan
Prior art keywords
antibody
bio
mammal
acid
material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP20104787A
Other versions
JP2664906B2 (en
Inventor
Aaru Betsuku Rii
Original Assignee
Stolle Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stolle Res & Dev filed Critical Stolle Res & Dev
Priority to JP62201047A priority Critical patent/JP2664906B2/en
Publication of JPS6450824A publication Critical patent/JPS6450824A/en
Application granted granted Critical
Publication of JP2664906B2 publication Critical patent/JP2664906B2/en
Anticipated expiration legal-status Critical
Application status is Expired - Fee Related legal-status Critical

Links

Abstract

PURPOSE: To establish a high resistant value and lymphokinen level by inoculating an amount of antibody material smaller than that used in a conventional immunizing method by introducing the antibody material into a molding structure of a bio-compatible matrix and transplanting the structure into a mammal. CONSTITUTION: An antibody is introduced into a solid molding product of a matrix comprising a bio-compatible, biodegradable or bio-erosive polymer material, e.g. polylactic acid, polyglycolic acid, poly(lactic acid-co-glycolic acid), polycaprolactone, poly(oxalic acid), polydioxanone, polyorthoester, or a salt thereof, and transplanted into a mammal by an intramuscular injection or a hypodermic injection in the method for immunizing a mammal. The antibody is gradually released from the matrix material for a long period in a regulated rate. This method is effectively used by applying the one to an animal belonging to bovine group to produce an antibody and a lymphokinen factor in the milk.
JP62201047A 1987-08-13 1987-08-13 Immunization of improved mammal Expired - Fee Related JP2664906B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP62201047A JP2664906B2 (en) 1987-08-13 1987-08-13 Immunization of improved mammal

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62201047A JP2664906B2 (en) 1987-08-13 1987-08-13 Immunization of improved mammal

Publications (2)

Publication Number Publication Date
JPS6450824A true JPS6450824A (en) 1989-02-27
JP2664906B2 JP2664906B2 (en) 1997-10-22

Family

ID=16434525

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62201047A Expired - Fee Related JP2664906B2 (en) 1987-08-13 1987-08-13 Immunization of improved mammal

Country Status (1)

Country Link
JP (1) JP2664906B2 (en)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4986525A (en) * 1972-12-04 1974-08-19
US3887699A (en) * 1969-03-24 1975-06-03 Seymour Yolles Biodegradable polymeric article for dispensing drugs
JPS51118823A (en) * 1975-03-20 1976-10-19 Kreuter Joerg Production and use of super microscopic particle
JPS54113425A (en) * 1978-02-06 1979-09-05 Stolle Res & Dev Protecting and treating agent for rheumatism like arthritis
EP0007895A1 (en) * 1978-07-19 1980-02-06 Patrick Couvreur Biodegradable nanoparticles, pharmaceutical compositions containing them and process for their preparation
JPS5555114A (en) * 1978-10-17 1980-04-22 Stolle Res & Dev Fine drug
EP0064103A1 (en) * 1981-04-28 1982-11-10 The Stolle Research And Development Corporation Method of obtaining an anti-inflammatory bovine milk
JPS63190833A (en) * 1986-10-24 1988-08-08 Southern Res Inst Method and composition for orally administrating physiological substance to animals

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3887699A (en) * 1969-03-24 1975-06-03 Seymour Yolles Biodegradable polymeric article for dispensing drugs
JPS4986525A (en) * 1972-12-04 1974-08-19
JPS51118823A (en) * 1975-03-20 1976-10-19 Kreuter Joerg Production and use of super microscopic particle
JPS54113425A (en) * 1978-02-06 1979-09-05 Stolle Res & Dev Protecting and treating agent for rheumatism like arthritis
EP0007895A1 (en) * 1978-07-19 1980-02-06 Patrick Couvreur Biodegradable nanoparticles, pharmaceutical compositions containing them and process for their preparation
JPS5555114A (en) * 1978-10-17 1980-04-22 Stolle Res & Dev Fine drug
EP0064103A1 (en) * 1981-04-28 1982-11-10 The Stolle Research And Development Corporation Method of obtaining an anti-inflammatory bovine milk
JPS63190833A (en) * 1986-10-24 1988-08-08 Southern Res Inst Method and composition for orally administrating physiological substance to animals

Also Published As

Publication number Publication date
JP2664906B2 (en) 1997-10-22

Similar Documents

Publication Publication Date Title
Huang et al. In vitro characterization of human dental pulp cells: various isolation methods and culturing environments
Zimmermann et al. Cardiac tissue engineering for replacement therapy
Martin et al. Selective differentiation of mammalian bone marrow stromal cells cultured on three‐dimensional polymer foams
Noël et al. Enhancement of tumorigenicity of human breast adenocarcinoma cells in nude mice by matrigel and fibroblasts
Kloss et al. Effect of lipopolysaccharide on the morphology and integrin immunoreactivity of ramified microglia in the mouse brain and in cell culture
Like et al. Embryogenesis of the human pancreatic islets: a light and electron microscopic study
Mainil‐Varlet et al. Effect of in vivo and in vitro degradation on molecular and mechanical properties of various low‐molecular‐weight polylactides
Li et al. Biodegradation of aliphatic polyesters
Peters et al. Release from alginate enhances the biological activity of vascular endothelial growth factor
Okada chapter 11 Cellular Metaplasia or Transdifferentiaton as a Model for Retinal Cell Differentiation
US6392118B1 (en) Mx-1 conditionally immortalized cells
US7470425B2 (en) Population of undifferentiated neural, endocrine or neuroendocrine cells in a hydrogel support
Yannas et al. Synthesis and characterization of a model extracellular matrix that induces partial regeneration of adult mammalian skin
CA1338839C (en) Controlled release formulation
Yamada et al. Bone regeneration following injection of mesenchymal stem cells and fibrin glue with a biodegradable scaffold
Carver et al. Influence of intermittent pressure, fluid flow, and mixing on the regenerative properties of articular chondrocytes
Fullilove et al. Nuclear elongation and cytokinesis in Drosophila montana
Lam et al. The effect of phagocytosis of poly (L‐lactic acid) fragments on cellular morphology and viability
US4997443A (en) Transplantable artificial tissue and process
US5468787A (en) Biomaterials for tissue repair
US6051750A (en) Method and construct for producing graft tissue from an extracellular matrix
Perka et al. Matrix‐mixed culture: New methodology for chondrocyte culture and preparation of cartilage transplants
Dobrinski et al. Germ cell transplantation from large domestic animals into mouse testes
DE69818052T2 (en) Open-pored biodegradable matrix
Ibaraki et al. Effects of growth factors on proliferation and differentiation in human lens epithelial cells in early subculture.

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees